CM Life Sciences III Inc.

667 Madison Avenue

New York, NY 10065

 

November 30, 2021

 

VIA EDGAR

 

Division of Corporation Finance Office of Life Sciences
Securities and Exchange Commission
100 F Street, N.E.

Washington, D.C. 20549

Attention: Jordan Nimitz and Chris Edwards

 

  Re: CM Life Sciences III Inc.
    Amendment No. 4 to Registration Statement on Form S-4
    Filed November 30, 2021
    File No. 333-259054

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission promulgated under the Securities Act of 1933, as amended, CM Life Sciences III Inc. hereby respectfully requests that the effective date of the above-captioned Registration Statement on Form S-4, as amended (the “Registration Statement”) be accelerated to, and that the Registration Statement be declared effective at, 4 p.m., prevailing Eastern Time, on December 1, 2021, or as soon as practicable thereafter.

 

Please contact A.J. Ericksen (AJ.ericksen@whitecase.com / telephone: (713) 496-9688) or Marie Elena Angulo (marie.elena.angulo@whitecase.com / telephone: (305) 995-5263) of White & Case LLP with any questions and please notify one or more of them when this request for acceleration has been granted.

 

Sincerely,

 

  By: /s/ Brian Emes
  Name:  Brian Emes
  Title: Chief Financial Officer and Secretary

 

cc: A.J. Ericksen, White & Case LLP
  Marie Elena Angulo, White & Case LLP